These factors are not only prevalent but often pivotal in determining disease progression and treatment response in human neurological populations
Mayer EA, Tillisch K, Gupta A
It also contributes to heterogeneity in trial designs, encompassing a broad array of endpoints, mechanisms of action, and timescales
The findings of this study are significant for two reasons: 1) GHK is a natural peptide and if it demonstrates anticancer effects it will be an excellent candidate for chemotherapy, and 2) GHK can be modified by PEGylation and once modified it can then be used for both wound healing and chemotherapy
Thus, it can be speculated that the dynamic expression of AA transporters on mammary gland cells along lactation contributes to the FAA dynamics in human milk
A qualified healthcare provider should assess your individual health status and biomarkers before recommending your specific starting dose